loading page

Experiences from the Initial Three Years of Introducing the BPS/MSC Prescribing Safety Assessment for Danish Junior Doctors
  • +1
  • Kathrine Moriat,
  • Zandra Ennis,
  • Thomas Øhlenschlæger,
  • Troels K. Bergmann
Kathrine Moriat
Odense Universitetshospital

Corresponding Author:[email protected]

Author Profile
Zandra Ennis
Odense Universitetshospital
Author Profile
Thomas Øhlenschlæger
Odense Universitetshospital
Author Profile
Troels K. Bergmann
Odense Universitetshospital
Author Profile

Abstract

Aim: The British Pharmacological Society and UK Medical Schools Council Prescription Safety Assessment (BPS/MSC PSA) is an electronic platform developed for assessing the prescription skills of medical students. Our aim was to investigate the feasibility of the PSA in addressing prescribing competencies among junior doctors in a hospital setting. Methods: The Department of Clinical Pharmacology at Odense University Hospital (OUH) established a Danish translated program using the BPS/MSC PSA platform. We launched a formal three year program in 2021, potentially assessing all first-year doctors at OUH and Esbjerg Regional Hospital. Participation was mandatory, followed by a survey (not mandatory). Results: During the period of 2021 to 2023 n= 364 doctors were invited, from which n=246 participated. The compliance rate increased from 38% in 2021 to 88% in 2023. The mean assessment score (points normalized to percentage) across n=246 participants was 71%, and 94% achieved a score of at least 50%. The survey was distributed to n=402 with 90 responses (22%) from which n=71 completed the questionnaire. Of these, 64% stated that the purpose with the assessment was clear. The two questions about difficulty level and the number of questions had similar evaluations. The majority of respondents found that the questions were of clinical relevance. Conclusion: It is feasible to translate and implement the PSA in a Danish hospital setting. The program provides insight into the prescribing competencies of junior doctors and the participants are generally positive.
Submitted to British Journal of Clinical Pharmacology
29 May 2024Review(s) Completed, Editorial Evaluation Pending
31 May 2024Reviewer(s) Assigned
26 Jun 2024Editorial Decision: Revise Major
13 Sep 20241st Revision Received
16 Sep 2024Submission Checks Completed
16 Sep 2024Assigned to Editor
16 Sep 2024Review(s) Completed, Editorial Evaluation Pending
23 Sep 2024Editorial Decision: Accept